Compare Skyworks Solutions Inc (SWKS) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Skyworks Solutions Inc vs Tenet Healthcare Corporation — how do they compare? Skyworks Solutions Inc trades at $78.89 (market cap $12.15B), while Tenet Healthcare Corporation trades at $260 (market cap $20.98B). The key difference: Tenet Healthcare Corporation is the larger of the two by market cap, and Skyworks Solutions Inc pays a 4.13% dividend while Tenet Healthcare Corporation pays none. Which is the better fit depends on your goals — on Pluang, investors hold Skyworks Solutions Inc for 50 Days and Tenet Healthcare Corporation for 15 Days on average.
| SWKS | THC | |
|---|---|---|
Market Cap | $12.15B | $20.98B |
Volume | 7,390,810 | 428,008 |
Sector | Technology | Health |
52-Week High | $91.45 | $280.77 |
52-Week Low | $52.50 | $161.37 |
Typical Hold Time | 50 Days | 15 Days |
Enterprise Value | $12.03B | $32.06B |
Dividend Yield | 4.13% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Skyworks Solutions (SWKS) trades at $83.43, up 0.88% with neutral technical signals. The stock shows declining revenue from $4.8B in 2023 to $4.1B in 2025 and contracting profit margins from 20.59% to 11.67% over the same period. Recent Q2 2026 earnings beat expectations at $1.08 EPS versus $1.03 expected. The pending Qorvo merger, expected to close in 2026 with $500M in synergies, represents a major strategic shift that could enhance scale and market positioning.
While analyst consensus remains bullish (60% buy ratings) with a $78.80 price target, near-term risks include execution challenges with the merger integration and ongoing revenue pressure. The current P/E of 43.23 appears elevated relative to earnings growth trends, suggesting investors should weigh merger benefits against fundamental deterioration.
Tenet Healthcare (THC) trades at $259.83, up 0.53% with a bullish technical signal. The stock shows strong fundamentals with consistent earnings beats (Q4 2025-Q2 2026) and robust profitability (ROE 53.31%, net margin 9.9%). Recent news highlights strong cash flow supporting capital returns and upcoming Q3 2026 results on October 29. Valuation appears reasonable with P/E of 10.07 and EV/EBITDA of 5.75.
THC presents a compelling investment case with strong analyst support (81% buy ratings) and 7% upside to consensus target of $283.36. Key catalysts include sustained earnings momentum and efficient capital allocation. Risks include surgical volume pressures and cash flow sustainability concerns amid aggressive buybacks. The stock's current technical setup near pivot point $259 suggests balanced risk-reward.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Skyworks Solutions Inc
Skyworks Solutions produces semiconductors for wireless handsets and other devices that are used to enable wireless connectivity. Its main products include power amplifiers, filters, switches, and integrated front-end modules that support wireless transmissions. Skyworks' customers are mostly large smartphone manufacturers, but the firm also has a growing presence in nonhandset applications such as wireless routers, medical devices, and automobiles.
Read more on SWKS →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
